Loading…
for educational and safety purposes
Flubromazepam and Flubromazolam both come up in the same conversations; they overlap on GABA. Flubromazepam: Flubromazepam is a designer benzodiazepine notable for an extremely long duration; a single dose can produce effects and residual impairment lasting into multiple days. Flubromazolam: Flubromazolam is a designer benzodiazepine and one of the most potent known, active in extraordinarily small amounts.
Flubromazepam is a designer benzodiazepine notable for an extremely long duration; a single dose can produce effects and residual impairment lasting into multiple days. It enhances GABA at the GABA-A receptor for sedation, anxiety relief and muscle relaxation. Its very long half-life makes accumulation and next-day impairment a particular hazard, on top of the usual benzodiazepine risks.
Flubromazolam is a designer benzodiazepine and one of the most potent known, active in extraordinarily small amounts. It is a triazolo compound that enhances GABA to produce very heavy sedation, amnesia and, at higher doses, prolonged unconsciousness. Its combination of extreme potency and long duration makes it exceptionally dangerous and it has been linked to serious poisonings.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Positive allosteric modulator
Positive allosteric modulator
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.